造血干细胞的衰老促进了TET2 克隆性造血
Research square
|February 23, 2026
概括
衰老通过降低正常造血干细胞 (HSC) 的适应性来加速克隆造血 (CH). 2无活化取消了与衰老相关的变化,促进了CH的发展.
科学领域:
- 血液学 血液学 血液学
- 衰老的研究研究.
- 癌症生物学 癌症生物学
背景情况:
- 衰老与克隆性血液形成 (CH) 和骨髓质恶性瘤有关.
- 衰老对CH突变的克隆选择的影响仍然不清楚.
研究的目的:
- 调查衰老在具有CH突变的造血干细胞 (HSC) 克隆扩张中的作用.
- 阐明衰老促进CH的机制.
主要方法:
- 利用一种涉及Tet2淘汰赛 (KO) 造血干细胞 (HSC) 的CH小鼠模型.
- 比较了不同年龄的接受者中老和年轻的捐赠小鼠中的HSC扩张率.
- 从小鼠和人类中分析了老年和年轻的HSC中的基因表达模式和细胞反应.
主要成果:
- 从老捐赠者移植的Tet2 KO HSC比年轻的HSC扩张得更快,无论接受者的年龄如何.
- 这种加速扩张在中年时显而易见,并归因于老年竞争对手非突变HSC.的体力减弱.
- 老年HSC显示RUNX1活性和核糖体蛋白基因表达增加,触发了p53介导的应激反应,Tet2/TET2无活化逆转了这种反应.
结论:
- 衰老创造了一个有利于Tet2,Runx1和Trp53突变HSC的克隆扩张的环境.
- 这一过程促进了克隆性血液形成和潜在的骨髓性恶性瘤的发展.
相关概念视频
Multipotency of Hematopoietic Stem Cells
4.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K
Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Hematopoiesis
9.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.3K
Replicative Cell Senescence
4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K


